Fundraising FoxBioverge — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Modulo Biomodulo.bioin𝕏Jun 2023
Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.
AI & Machine LearningBiotechDeep TechLos Altos, US
Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)
BoardAlda Leu Dennis(Director)inNicholas Saccomano(Director)
Co-investorsCantos VenturesGaingelsHAWKTAILInitialized CapitalLifespan Vision VenturesMana Ventures+3 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.